|
|
|
Page 12
|
|
Capabilities
|
|
People
AFRIMS
employs over 250 people, including 20 US officers and enlisted
personnel, 120 Thai scientific, technical and administrative
personnel, and numerous contractors and visiting scientists.
AFRIMS undertakes collaborative projects not only with other
US military research units, but also with the Thai government
and with scientists in universities in Thailand and in other
countries worldwide.
|
|
|
|
|
|
Preparation
of standard curve solutions in human plasma for in vitro
bioassay of artemisinin compounds. AFRIMS is a technologic
leader in artemisinin chemical and bioassay measurement.
Counting
plaques, a dengue plaque reduction neutralization assay.
Such testing is critical for research for dengue vaccine
development.
A
medical technologist determines blood parameters utilizing
an automated, quantitative hematology analyzer.
|
|
Resources
Over half the budget comes from US Army Medical Research
and Materiel Command (USAMRMC). The remainder comes from
collaborative projects supported by the World Health Organization,
the National Institute of Health, the National Academy of
Sciences, and private corporations and research foundations.
USAMRMC, unlike private pharmaceutical companies, is concerned
with medical threats to military deployment, and thus is
not limited to only drug or vaccine development which has
commercial potential. While private industry may be unable
to invest the millions of dollars necessary to combat tropical
diseases, pharmaceutical companies are often willing to
enter into cooperative agreements with AFRIMS to develop
and test new drugs and vaccines. Nearly one-half of the
budget of AFRIMS now comes from such partnerships with the
private sector.
A
technician performs clinical chemistry determinations with
an automated analyzer that requires only
10 microliter biosample per test - a useful feature when
evaluating amall animal models of human disease.
|
Back
to About AFRIMS
|
|
